Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.

ABSTRACT:

SUBMITTER: Folegatti PM 

PROVIDER: S-EPMC7445431 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature